Guangzhou Baiyunshan Pharmaceutical Sets 21 August 2026 Board Meeting to Review H1 2026 Unaudited Results

Bulletin Express

08/10

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced that its board of directors will convene on 21 August 2026 to consider and approve the unaudited financial results for the six months ended 30 June 2026. Additional business matters, if any, may also be addressed at the session.

The notice was issued from Guangzhou on 10 August 2026. As disclosed, the Board currently comprises six executive directors—Chen Jiehui, Yuan Cheng, Cheng Hongjin, Tang Heping, Liu Lan and Liu Hong—one non-executive director, Huang Jiyuan, and four independent non-executive directors: Wong Lung Tak Patrick, Sun Baoqing, Wu Xiangneng and Yang Yinbao.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1162133779"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1162133779\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1162133779?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-10 17:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162133779","market":"us","top_or_hot":-1,"title":"Guangzhou Baiyunshan Pharmaceutical Sets 21 August 2026 Board Meeting to Review H1 2026 Unaudited Results","media":"Bulletin Express","content":"<p>Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced that its board of directors will convene on 21 August 2026 to consider and approve the unaudited financial results for the six months ended 30 June 2026. Additional business matters, if any, may also be addressed at the session.</p>\n<p>The notice was issued from Guangzhou on 10 August 2026. As disclosed, the Board currently comprises six executive directors—Chen Jiehui, Yuan Cheng, Cheng Hongjin, Tang Heping, Liu Lan and Liu Hong—one non-executive director, Huang Jiyuan, and four independent non-executive directors: Wong Lung Tak Patrick, Sun Baoqing, Wu Xiangneng and Yang Yinbao.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guangzhou Baiyunshan Pharmaceutical Sets 21 August 2026 Board Meeting to Review H1 2026 Unaudited Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuangzhou Baiyunshan Pharmaceutical Sets 21 August 2026 Board Meeting to Review H1 2026 Unaudited Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-10 17:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced that its board of directors will convene on 21 August 2026 to consider and approve the unaudited financial results for the six months ended 30 June 2026. Additional business matters, if any, may also be addressed at the session.</p>\n<p>The notice was issued from Guangzhou on 10 August 2026. As disclosed, the Board currently comprises six executive directors—Chen Jiehui, Yuan Cheng, Cheng Hongjin, Tang Heping, Liu Lan and Liu Hong—one non-executive director, Huang Jiyuan, and four independent non-executive directors: Wong Lung Tak Patrick, Sun Baoqing, Wu Xiangneng and Yang Yinbao.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00874","symbol_name":"白云山","start_time":0,"source_url":"","article_id":"1162133779","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162133779","pubTimestamp":1786355142,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced that its board of directors will convene on 21 August 2026 to consider and approve the unaudited financial results for the six...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00874":"白云山"},"translate_title":"广州白云山药业于2026年8月21日召开董事会会议，审阅2026年上半年未经审核业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00874":1},"content_text":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced that its board of directors will convene on 21 August 2026 to consider and approve the unaudited financial results for the six months ended 30 June 2026. Additional business matters, if any, may also be addressed at the session.\nThe notice was issued from Guangzhou on 10 August 2026. As disclosed, the Board currently comprises six executive directors—Chen Jiehui, Yuan Cheng, Cheng Hongjin, Tang Heping, Liu Lan and Liu Hong—one non-executive director, Huang Jiyuan, and four independent non-executive directors: Wong Lung Tak Patrick, Sun Baoqing, Wu Xiangneng and Yang Yinbao.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}